{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:11:05Z","timestamp":1788023465413,"version":"build-2784847793"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Natural Science Foundation of Gansu Province","award":["23JRRA0939"],"award-info":[{"award-number":["23JRRA0939"]}]},{"name":"Lanzhou Science and Technology Program","award":["2023-1-19"],"award-info":[{"award-number":["2023-1-19"]}]},{"name":"Gansu Province Higher Education Project for Teaching Achievement Cultivation","award":["202314-16"],"award-info":[{"award-number":["202314-16"]}]},{"name":"Medical Innovation and Development Project of Lanzhou University","award":["lzuyxcx-2022-41"],"award-info":[{"award-number":["lzuyxcx-2022-41"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04057-w","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:30:40Z","timestamp":1751355040000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of serum lactate dehydrogenase levels with non-alcoholic fatty liver disease and advanced hepatic fibrosis in the United States: a cross-sectional study using NHANES data from 2007 to 2018"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaotong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"16","key":"4057_CR1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P. Nonalcoholic fatty liver disease. N Engl J Med. 2002;346(16):1221\u201331.","journal-title":"N Engl J Med"},{"issue":"2","key":"4057_CR2","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/HEP.0000000000000545","volume":"79","author":"JV Lazarus","year":"2024","unstructured":"Lazarus JV, Mark HE, Allen AM, Arab JP, Carrieri P, Noureddin M, Alazawi W, Alkhouri N, Alqahtani SA, Anstee QM, Arrese M, Bataller R, Berg T, Brennan PN, Burra P, Castro-Narro GE, Cortez-Pinto H, Cusi K, Dedes N, Duseja A, Francque SM, Gastaldelli A, Hagstr\u00f6m H, Huang TTK, Ivancovsky Wajcman D, Kautz A, Kopka CJ, Krag A, Newsome PN, Rinella ME, Romero D, Sarin SK, Silva M, Spearman CW, Terrault NA, Tsochatzis EA, Valenti L, Villota-Rivas M, Zelber-Sagi S, Schattenberg JM, Wong VW, Younossi ZM. A global action agenda for turning the tide on fatty liver disease. Hepatology. 2024;79(2):502\u201323.","journal-title":"Hepatology"},{"issue":"1","key":"4057_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, Bugianesi E. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15(1):11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1 Suppl","key":"4057_CR4","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","volume":"62","author":"CD Byrne","year":"2015","unstructured":"Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(1 Suppl):S47-64.","journal-title":"J Hepatol"},{"issue":"1","key":"4057_CR5","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, Brunt EM, Sanyal AJ. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2018;67(1):328\u201357.","journal-title":"Hepatology"},{"issue":"1","key":"4057_CR6","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"1","key":"4057_CR7","first-page":"48","volume":"30","author":"M Rashid","year":"2000","unstructured":"Rashid M, Roberts EA. Nonalcoholic steatohepatitis in children. J Pediatr Gastroenterol Nutr. 2000;30(1):48\u201353.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"4057_CR8","first-page":"408","volume":"3","author":"A Kinugasa","year":"1984","unstructured":"Kinugasa A, Tsunamoto K, Furukawa N, Sawada T, Kusunoki T, Shimada N. Fatty liver and its fibrous changes found in simple obesity of children. J Pediatr Gastroenterol Nutr. 1984;3(3):408\u201314.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"21","key":"4057_CR9","doi-asserted-by":"publisher","first-page":"3805","DOI":"10.3748\/wjg.v23.i21.3805","volume":"23","author":"Y Tan","year":"2017","unstructured":"Tan Y, Kim J, Cheng J, Ong M, Lao WG, Jin XL, Lin YG, Xiao L, Zhu XQ, Qu XQ. Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats. World J Gastroenterol. 2017;23(21):3805\u201314.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"4057_CR10","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1056\/NEJM200102153440706","volume":"344","author":"AA Bravo","year":"2001","unstructured":"Bravo AA, Sheth SG, Chopra S. Liver biopsy. N Engl J Med. 2001;344(7):495\u2013500.","journal-title":"N Engl J Med"},{"issue":"11","key":"4057_CR11","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.5858\/132.11.1761","volume":"132","author":"G Guzman","year":"2008","unstructured":"Guzman G, Brunt EM, Petrovic LM, Chejfec G, Layden TJ, Cotler SJ. Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Arch Pathol Lab Med. 2008;132(11):1761\u20136.","journal-title":"Arch Pathol Lab Med"},{"issue":"4","key":"4057_CR12","doi-asserted-by":"publisher","first-page":"E496","DOI":"10.1152\/ajpendo.00061.2018","volume":"315","author":"T Wang","year":"2018","unstructured":"Wang T, Yao W, Li J, He Q, Shao Y, Huang F. Acetyl-CoA from inflammation-induced fatty acids oxidation promotes hepatic malate-aspartate shuttle activity and glycolysis. Am J Physiol Endocrinol Metab. 2018;315(4):E496-e510.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"28","key":"4057_CR13","doi-asserted-by":"publisher","first-page":"9330","DOI":"10.3748\/wjg.v20.i28.9330","volume":"20","author":"S Mili\u0107","year":"2014","unstructured":"Mili\u0107 S, Luli\u0107 D, \u0160timac D. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations. World J Gastroenterol. 2014;20(28):9330\u20137.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"4057_CR14","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0021-9258(18)98146-9","volume":"234","author":"WB Novoa","year":"1959","unstructured":"Novoa WB, Winer AD, Glaid AJ, Schwert GW. Lactic dehydrogenase. V. Inhibition by oxamate and by oxalate. J Biol Chem. 1959;234(5):1143\u20138.","journal-title":"J Biol Chem."},{"issue":"1","key":"4057_CR15","doi-asserted-by":"publisher","first-page":"12997","DOI":"10.1038\/s41598-021-92430-6","volume":"11","author":"Y Wu","year":"2021","unstructured":"Wu Y, Lu C, Pan N, Zhang M, An Y, Xu M, Zhang L, Guo Y, Tan L. Serum lactate dehydrogenase activities as systems biomarkers for 48 types of human diseases. Sci Rep. 2021;11(1):12997.","journal-title":"Sci Rep"},{"issue":"5","key":"4057_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1001\/jamaophthalmol.2013.2597","volume":"131","author":"X Zhang","year":"2013","unstructured":"Zhang X, Bullard KM, Cotch MF, Wilson MR, Rovner BW, McGwin G Jr, Owsley C, Barker L, Crews JE, Saaddine JB. Association between depression and functional vision loss in persons 20 years of age or older in the United States, NHANES 2005\u20132008. JAMA Ophthalmol. 2013;131(5):573\u201381.","journal-title":"JAMA Ophthalmol"},{"key":"4057_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jad.2016.11.035","volume":"209","author":"Kenneson A, Funderburk JS","year":"2017","unstructured":"Kenneson A, Funderburk JS. Patatin-like phospholipase domain-containing protein 3 (PNPLA3): A potential role in the association between liver disease and bipolar disorder. J Affect Disord. 2017;209:93\u20136.","journal-title":"J Affect Disord"},{"key":"4057_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-230X-6-33","volume":"6","author":"G Bedogni","year":"2006","unstructured":"Bedogni G, Bellentani S, Miglioli L, Masutti F, Passalacqua M, Castiglione A, Tiribelli C. The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population. BMC Gastroenterol. 2006;6:33.","journal-title":"BMC Gastroenterol"},{"issue":"3","key":"4057_CR19","first-page":"261","volume":"5","author":"MC Cheah","year":"2017","unstructured":"Cheah MC, McCullough AJ, Goh GB. Current Modalities of Fibrosis Assessment in Non-alcoholic Fatty Liver Disease. J Clin Transl Hepatol. 2017;5(3):261\u201371.","journal-title":"J Clin Transl Hepatol"},{"issue":"1","key":"4057_CR20","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1186\/s12889-022-14360-w","volume":"22","author":"Q Liu","year":"2022","unstructured":"Liu Q, Kang Y, Yan J. Association between overall dietary quality and constipation in American adults: a cross-sectional study. BMC Public Health. 2022;22(1):1971.","journal-title":"BMC Public Health"},{"issue":"22","key":"4057_CR21","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313(22):2263\u201373.","journal-title":"JAMA"},{"issue":"2","key":"4057_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3390\/biomedicines9020145","volume":"9","author":"J Plaza-D\u00edaz","year":"2021","unstructured":"Plaza-D\u00edaz J, Solis-Urra P, Arag\u00f3n-Vela J, Rodr\u00edguez-Rodr\u00edguez F, Olivares-Arancibia J, \u00c1lvarez-Mercado AI. Insights into the Impact of Microbiota in the Treatment of NAFLD\/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis. Biomedicines. 2021;9(2):145.","journal-title":"Biomedicines"},{"key":"4057_CR23","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1146\/annurev-med-042220-020407","volume":"73","author":"Y Saiman","year":"2022","unstructured":"Saiman Y, Duarte-Rojo A, Rinella ME. Fatty Liver Disease: Diagnosis and Stratification. Annu Rev Med. 2022;73:529\u201344.","journal-title":"Annu Rev Med"},{"issue":"9","key":"4057_CR24","doi-asserted-by":"publisher","first-page":"Itc65","DOI":"10.7326\/AITC201811060","volume":"169","author":"XJ Wang","year":"2018","unstructured":"Wang XJ, Malhi H. Nonalcoholic Fatty Liver Disease. Ann Intern Med. 2018;169(9):Itc65-#x02212;itc80.","journal-title":"Ann Intern Med."},{"issue":"5","key":"4057_CR25","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.jacc.2005.12.003","volume":"47","author":"A Halkin","year":"2006","unstructured":"Halkin A, Stone GW, Grines CL, Cox DA, Rutherford BD, Esente P, Meils CM, Albertsson P, Farah A, Tcheng JE, Lansky AJ, Mehran R. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 2006;47(5):951\u201361.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4057_CR26","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11912-005-0065-2","volume":"7","author":"N Kounalakis","year":"2005","unstructured":"Kounalakis N, Goydos JS. Tumor cell and circulating markers in melanoma: diagnosis, prognosis, and management. Curr Oncol Rep. 2005;7(5):377\u201382.","journal-title":"Curr Oncol Rep"},{"issue":"11","key":"4057_CR27","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/iub.1216","volume":"65","author":"P Miao","year":"2013","unstructured":"Miao P, Sheng S, Sun X, Liu J, Huang G. Lactate dehydrogenase A in cancer: a promising target for diagnosis and therapy. IUBMB Life. 2013;65(11):904\u201310.","journal-title":"IUBMB Life"},{"issue":"10229","key":"4057_CR28","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","volume":"395","author":"F Zhou","year":"2020","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054\u201362.","journal-title":"Lancet"},{"issue":"6","key":"4057_CR29","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/hep.21877","volume":"46","author":"C Rose","year":"2007","unstructured":"Rose C, Ytreb\u00f8 LM, Davies NA, Sen S, Nedredal GI, Belanger M, Revhaug A, Jalan R. Association of reduced extracellular brain ammonia, lactate, and intracranial pressure in pigs with acute liver failure. Hepatology. 2007;46(6):1883\u201392.","journal-title":"Hepatology"},{"issue":"2","key":"4057_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.3892\/etm.2011.197","volume":"2","author":"K Kotoh","year":"2011","unstructured":"Kotoh K, Kato M, Kohjima M, Tanaka M, Miyazaki M, Nakamura K, Enjoji M, Nakamuta M, Takayanagi R. Lactate dehydrogenase production in hepatocytes is increased at an early stage of acute liver failure. Exp Ther Med. 2011;2(2):195\u20139.","journal-title":"Exp Ther Med"},{"key":"4057_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0167-5877(96)86352-5","volume":"28","author":"DL Doxey","year":"1996","unstructured":"Doxey DL. Laboratory profiles of small animal diseases: A guide to laboratory diagnosis. Prev Vet Med. 1996;28:133\u20135.","journal-title":"Prev Vet Med"},{"key":"4057_CR32","doi-asserted-by":"publisher","first-page":"1723184","DOI":"10.1155\/2018\/1723184","volume":"2018","author":"W Kong","year":"2018","unstructured":"Kong W, Zuo X, Liang H, Hu J, Zhang H, Wang X, Chen W. Prognostic Value of Lactate Dehydrogenase in Patients with Hepatocellular Carcinoma: A Meta-Analysis. Biomed Res Int. 2018;2018:1723184.","journal-title":"Biomed Res Int"},{"issue":"1\u20132","key":"4057_CR33","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s11010-013-1698-3","volume":"381","author":"A Mehrotra","year":"2013","unstructured":"Mehrotra A, Trigun SK. Moderate grade hyperammonemia activates lactate dehydrogenase-4 and 6-phosphofructo-2-kinase to support increased lactate turnover in the brain slices. Mol Cell Biochem. 2013;381(1\u20132):157\u201361.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"4057_CR34","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1080\/00952990.2016.1217539","volume":"43","author":"P Tan","year":"2017","unstructured":"Tan P, Liang H, Nie J, Diao Y, He Q, Hou B, Zhao T, Huang H, Li Y, Gao X, Zhou L, Liu Y. Establishment of an alcoholic fatty liver disease model in mice. Am J Drug Alcohol Abuse. 2017;43(1):61\u20138.","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"3","key":"4057_CR35","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3892\/ijmm.2020.4655","volume":"46","author":"J Xiong","year":"2020","unstructured":"Xiong J, Ni J, Chen C, Wang K. miR-148a-3p regulates alcoholic liver fibrosis through targeting ERBB3. Int J Mol Med. 2020;46(3):1003\u201312.","journal-title":"Int J Mol Med"},{"issue":"6","key":"4057_CR36","first-page":"3047","volume":"42","author":"JW Kim","year":"2018","unstructured":"Kim JW, Lee YS, Seol DJ, Cho IJ, Ku SK, Choi JS, Lee HJ. Anti-obesity and fatty liver-preventing activities of Lonicera caerulea in high-fat diet-fed mice. Int J Mol Med. 2018;42(6):3047\u201364.","journal-title":"Int J Mol Med"},{"issue":"6","key":"4057_CR37","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.jhep.2024.01.036","volume":"80","author":"XN Wu","year":"2024","unstructured":"Wu XN, Wang MZ, Zhang N, Zhang W, Dong J, Ke MY, Xiang JX, Ma F, Xue F, Hou JJ, Ma ZJ, Wang FM, Liu XM, Wu R, Pawlik TM, Ye K, Yu J, Zhang XF, Lyu Y. Sex-determining region Y gene promotes liver fibrosis and accounts for sexual dimorphism in its pathophysiology. J Hepatol. 2024;80(6):928\u201340.","journal-title":"J Hepatol"},{"key":"4057_CR38","doi-asserted-by":"publisher","first-page":"E89","DOI":"10.5888\/pcd21.240264","volume":"21","author":"M Zakeri","year":"2024","unstructured":"Zakeri M, Lal LS, Abughosh SM, Sansgiry S, Essien EJ, Sansgiry SS. Racial and Ethnic Disparities in Perceived Health Status Among Patients With Cardiovascular Disease. Prev Chronic Dis. 2024;21:E89.","journal-title":"Prev Chronic Dis"},{"issue":"7","key":"4057_CR39","first-page":"700","volume":"36","author":"P Szybowska","year":"2015","unstructured":"Szybowska P, Wojcik M, Starzyk JB, Sztefko K. Enhanced liver fibrosis (ELF) test in obese children with ultrasound-proven liver steatosis. Neuro Endocrinol Lett. 2015;36(7):700\u20135.","journal-title":"Neuro Endocrinol Lett"},{"issue":"1","key":"4057_CR40","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1186\/s12889-025-21322-5","volume":"25","author":"H Peng","year":"2025","unstructured":"Peng H, Zhao Z, Gong J, He K. BMI trajectories are associated with NAFLD and advanced fibrosis via aging-inflammation mediation. BMC Public Health. 2025;25(1):147.","journal-title":"BMC Public Health"},{"key":"4057_CR41","doi-asserted-by":"publisher","first-page":"1539283","DOI":"10.3389\/fmed.2025.1539283","volume":"12","author":"Z Gao","year":"2025","unstructured":"Gao Z, Deng H, Qin B, Bai L, Li J, Zhang J. Impact of hypertension on liver fibrosis in patients with metabolic dysfunction-associated fatty liver disease. Front Med (Lausanne). 2025;12:1539283.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"4057_CR42","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1007\/s12072-023-10625-7","volume":"18","author":"X Ma","year":"2024","unstructured":"Ma X, Zhu Y, Yeo YH, Fan Z, Xu X, Rui F, Ni W, Gu Q, Tong X, Yin S, Qi X, Shi J, Wu C, Li J. The impact of an increased Fibrosis-4 index and the severity of hepatic steatosis on mortality in individuals living with diabetes. Hepatol Int. 2024;18(3):952\u201363.","journal-title":"Hepatol Int"},{"issue":"4","key":"4057_CR43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1007\/s00535-007-2152-7","volume":"43","author":"K Iwamoto","year":"2008","unstructured":"Iwamoto K, Kanno K, Hyogo H, Yamagishi S, Takeuchi M, Tazuma S, Chayama K. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells. J Gastroenterol. 2008;43(4):298\u2013304.","journal-title":"J Gastroenterol"},{"issue":"8","key":"4057_CR44","doi-asserted-by":"publisher","first-page":"870","DOI":"10.3390\/nu9080870","volume":"9","author":"L Abenavoli","year":"2017","unstructured":"Abenavoli L, Greco M, Milic N, Accattato F, Foti D, Gulletta E, Luzza F. Effect of Mediterranean Diet and Antioxidant Formulation in Non-Alcoholic Fatty Liver Disease: A Randomized Study. Nutrients. 2017;9(8):870.","journal-title":"Nutrients"},{"issue":"6","key":"4057_CR45","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.3390\/nu15061501","volume":"15","author":"J Lee","year":"2023","unstructured":"Lee J, Jo G, Park D, Jun HJ, Bae JH, Shin MJ. The Association between Advanced Liver Fibrosis and Mortality Is Modified by Dietary Quality among Korean Adults: Results from the Korea National Health and Nutrition Examination Survey with Mortality Data. Nutrients. 2023;15(6):1501.","journal-title":"Nutrients"},{"issue":"12","key":"4057_CR46","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1038\/ng.257","volume":"40","author":"S Romeo","year":"2008","unstructured":"Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, Boerwinkle E, Cohen JC, Hobbs HH. Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet. 2008;40(12):1461\u20135.","journal-title":"Nat Genet"},{"issue":"5","key":"4057_CR47","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","volume":"21","author":"C Koliaki","year":"2015","unstructured":"Koliaki C, Szendroedi J, Kaul K, Jelenik T, Nowotny P, Jankowiak F, Herder C, Carstensen M, Krausch M, Knoefel WT, Schlensak M, Roden M. Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis. Cell Metab. 2015;21(5):739\u201346.","journal-title":"Cell Metab"},{"issue":"6","key":"4057_CR48","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1053\/j.gastro.2008.03.003","volume":"134","author":"SL Friedman","year":"2008","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655\u201369.","journal-title":"Gastroenterology"},{"issue":"1","key":"4057_CR49","doi-asserted-by":"publisher","first-page":"12933","DOI":"10.1038\/s41598-023-39641-1","volume":"13","author":"HK Chen","year":"2023","unstructured":"Chen HK, Luo J, Li XJ, Liao WZ, Hu YQ, Guo XG. Serum folate associated with nonalcoholic fatty liver disease and advanced hepatic fibrosis. Sci Rep. 2023;13(1):12933.","journal-title":"Sci Rep"},{"issue":"2","key":"4057_CR50","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.jhep.2018.03.016","volume":"69","author":"R Ferriero","year":"2018","unstructured":"Ferriero R, Nusco E, De Cegli R, Carissimo A, Manco G, Brunetti-Pierri N. Pyruvate dehydrogenase complex and lactate dehydrogenase are targets for therapy of acute liver failure. J Hepatol. 2018;69(2):325\u201335.","journal-title":"J Hepatol"},{"key":"4057_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107451","volume":"206","author":"TP Brown","year":"2020","unstructured":"Brown TP, Ganapathy V. Lactate\/GPR81 signaling and proton motive force in cancer: Role in angiogenesis, immune escape, nutrition, and Warburg phenomenon. Pharmacol Ther. 2020;206: 107451.","journal-title":"Pharmacol Ther"},{"key":"4057_CR52","doi-asserted-by":"publisher","first-page":"1102660","DOI":"10.3389\/fnut.2023.1102660","volume":"10","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Wang L, Lin Z, Yan W, Chen J, Zhang X, Ye W, Li J, Li Z. Dietary inflammatory index and risk of non-alcoholic fatty liver disease and advanced hepatic fibrosis in US adults. Front Nutr. 2023;10:1102660.","journal-title":"Front Nutr"},{"issue":"5","key":"4057_CR53","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jhep.2020.11.028","volume":"74","author":"T Wang","year":"2021","unstructured":"Wang T, Chen K, Yao W, Zheng R, He Q, Xia J, Li J, Shao Y, Zhang L, Huang L, Qin L, Xu M, Zhang Z, Pan D, Li Z, Huang F. Acetylation of lactate dehydrogenase B drives NAFLD progression by impairing lactate clearance. J Hepatol. 2021;74(5):1038\u201352.","journal-title":"J Hepatol"},{"issue":"1","key":"4057_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/apt.13012","volume":"41","author":"CE Ruhl","year":"2015","unstructured":"Ruhl CE, Everhart JE. Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther. 2015;41(1):65\u201376.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"4057_CR55","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson S, Stewart SF, Henderson E, Burt AD, Day CP. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 2010;59(9):1265\u20139.","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04057-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04057-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04057-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:03:10Z","timestamp":1751356990000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04057-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4057"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04057-w","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"29 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the NCHS Research Ethics Review Board (; accessed on August 24, 2022). NHANES was approved by the National Center for Health Statistics research ethics review board. Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"467"}}